Author, Subjects, Keywords

Cited Author

 

 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Dietary Fatty Acids in Growth and Development

Gibson, Robert A., and Makrides, Maria, (2000) Dietary Fatty Acids in Growth and Development. Malaysian Journal of Nutrition, 6 (2). pp. 171-179. ISSN 1394-035X

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
47Kb

Official URL: http://nutriweb.org.my/publications/mjn006/mjn6n2_art4.pdf

Affiliations

Child Nutrition Research Centre South Australia
Flinders Medical Centre South australia

Abstract

A newborn infant will double his/her weight in the first 3 months of life and double it again in the next year. Such a rapid growth rate demands adequate nutrition. Fat is a vital source of energy for the growing infant. In breast milk for example, 50% of the energy is in the form of fat. The fat of breast milk contains a full complement of polyunsaturated fatty acids (PUFA), including the two essential PUFA, linoleic acid (LA, 18:2 n-6) and a-linolenic acid, (ALA, 18:3 n-3) but also a range of long chain (LC) PUFA that have been shown to have benefits for both preterm and term infants. Until recently, infant formulas contained LA and ALA only, and this was thought to provide adequate fat nutrition since formula fed infants grew as well as breast-fed babies. LCPUFA are increasingly being added to infant formulas as the technical challenge relating to identifying sources that are stable and hence safe for infants have been overcome. The scope of this paper is to review some of the latest information available in the field of LCPUFA in infant nutrition, growth and development. While LA and ALA have biological activity in their own right, their activity is enhanced when they are converted to 20 and 22 carbon metabolites (LCPUFA) as they are readily incorporated into cell membranes and can be precursors of the potent hormones known collectively as eicosanoids. The main LCPUFA of interest during infancy are docosahexaenoic acid (DHA, 22:6 n-3) and arachidonic acid (M, 20:4 n-6). DHA and AA are found in many non-vegetable foods (breast milk, fish, meat, eggs) so can be obtained directly from the diet as well as by conversion of LA and ALA in the body. Growth is one of the most sensitive indicators of adequate nutritional status in infants and young children and for this reason is considered to be of key importance in all nutritional interventions. In the field of LCPUFA research the growth of infants randomly allocated to placebo or LCPUFA supplemented formulas has been used as a primary assessment of safety. One of the earliest and most cited trials involving preterm infants allocated to either a placebo, unsupplemented formula or one supplemented with a high EPA fish oil claimed that normalized weight and length of fish oil supplemented formula infants was less than that of infants fed unsupplemented formula at each assessment time between term and 12 months corrected age. It was postulated that low levels of AA, caused by the high n-3 LCPUFA content of the formula, were related to poor growth achievement in preterm infants. Phospholipid AA was correlated to normalized weight and length. However, it is interesting to note that more recent reports have not confirmed these findings. The failure of the later preterm studies to detect an effect of LCPUFA on growth has been suggested to be due to the balance of AA and DHA. It may also be that the growth of infants in these early studies was affected by factors other than the dietary fats. There are several studies underway to clarify this issue.

Item Type:Journal
Keywords:Polyunsaturated Fatty Acid (PUFA), Preterm Infants, Term Infants, Infant Development
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:2672

1. Agostoni C, Trojan S, BeIlCi R, Riva E, Bruzzese MG & Giovannini M (1997). Developmental quotient at 24 months and fatty acid composition of diet in early infancy: A follow up study. Arch Dis Child 6:421A.

2. Agostoni C, Trojan S, BelICI R, Riva E & Giovannini M (1995). Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: The role of long-chain polyunsaturated fatty acids. Pediatr Res 38:2626.

3. Auestad N, Montalto MB, Hall RT, et al. (1997). Visual acuity, erythrocyte fatty acid composition, and growth in term infants fed formulas with long chain polyunsaturated fatty acids for one year. Pediatr Res 41:1-10.

4. Birch DG, Birch EE, Hoffman DR & Uauy RD (1992b). Retinal development in very-low-birth-weight infants fed diets differing in omega-3 fatty acids. Invest Ophthalmol Vis Sci 33:2365-76.

5. Birch EE, Birch DG, Hoffman DR, et al. (1996). Visual maturation of term infants fed w3 long chain polyunsaturated fatty acid (LCPUFA) supplemented formula.. Invest Ophthalmol Vis Sci 37:SI I 12 (abstr).

6. Birch EE, Birch DG, Hoffman DR & Uauy R (1992a). Dietary essential fatty acid supply and visual acuity development. Invest Ophthalmol Vis Sci 32:3242-53.

7. Birch EE, Hoffman DR, Uauy R & Birch DG Prestidge C (1998). Visual acuity and the essentiality of docosahexanoic acid and arachidonic acid in the diet of term infants. Pediatr Res 44:201-9.

8. Carlson 5E, Ford AJ, Werkman SH, Peeples JM & Koo WWK (1996b). Visual acuity and fatty acid status of term infants fed human milk and formulas with and without docosahexaenoate and arachidonate from egg yolk lecithin. Pediatr Res 9: 882-8

9. Carlson SE, Cooke RJ, Werkman SH & Tolley EA (1992). First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula. Lipids 27:901-7.

10. Carlson SE, Ford AJ, Peeples JM & Werkman SH (1995). Visual acuity in term infants fed human milk or randomly assigned to a formula with or without long chain n-3 and n~fatty acids. Pediatr Res 37:303A (abstr).

11. Carlson SE, Werkman SH & Tolley EA (1996a). Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. Am J Clin Nutr 63:687-97.

12. Carlson SE, Werkman SH, Peeples JM, Cooke RJ & Tolley EA (1993a). Arachidonic acid status correlates with first year growth in preterm infants. Proc Nat Acad Sci USA 90:1073-7.

13. Carlson SE, Werkman SH, Peeples JM & Wilson WM (1994). Long-chain fatty acids and early visual and cognitive development of preterm infants. Eur J Clin Nutr 48 (Suppl 2):527-30.

14. Carlson SE, Werkman SH, Rhodes PG & Tolley EA (1993a). Visual acuity development in healthy preterm infants: effect of marine oil supplementation. Am J Clin Nutr 58:35A2.

15. Carlson SE & Werkman SH (1996). A randomized trial of visual attention of preterm infants fed docosahexaenoic fed until two months. Lipids 31:85-90

16. Clausen U, Damli A, Schenck UV & Koletzko B (1996). Influence of long-chain polyunsaturated fatty acids (LCPUFA) on early visual acuity and mental development of term infants. In PUFA in Infant Nutrition: Consensus and Controversies. November, 12(abst).

17. Damli A, Schenck UV, Clausen U & Koletzko B (1996). Effects of long-chain polyunsaturated fatty acids (LCPUFA) on early visual acuity and mental development of preterm infants. In PUFA in Infant Nutrition: Concensus and Controversies. November, 14(abst).

18. Faldella G, Govoni M, Alessandroni R, et al. (1996). Visual evoked potentials and dietary long chain polyunsaturated fatty acids in preterm infants. Arch Dis Child Fetal Neonatal 75:F108-12.

19. Gibson R, Neumann M & Makrides M (1997a). A randomised clinical trial of long chain fatty acids in term infants: effect on neural indices. J Paediatr Child Health 33:A8(abstr).

20. Gibson RA & Makrides M (1998). Polyunsaturated fatty adds and infant visual development: a critical appraisal of randomised clinical trials. Lipids (in press).

21. Gibson RA & Neumann MA, Makrides M (1997b). Effect of increasing breast milk docosahexanoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants. Eur J Clin Nutr 51:57884.

22. Hansen J, Schade D, Harris C et al. (1997). Docosahexaenoic acid plus arachidonic acid enhance preterm infant growth. Prostaglandins Leukot Essent Fatty Acids 57:96(abstr).

23. Janowsky JS, Scott DT, Wheeler RE & Auestad N (1995). Fatty acids affect early language development. Pediatr Res 37:310A (abstr).

24. Jensen CL, Prager TC, Fraley JK & Chen HM, Anderson RE, Heird WC (1997). Effect of dietary linoleidalpha-linolenic acid ratio on growth and visual function of term infants. J Pediatr 131:200-9.

25. Jorgensen MH, Holmer G, Lund P, Hernell O & Michaelsen, KF (1998). Effect of formula supplemented with docosahexaenoic add and gamma-linolenic acid on fatty acid status and visual acuity in term infants. Journal of Pediatric Gastroenterology & Nutrition 26:412-21.

26. Makrides M & Gibson RA (1998). Are long chain polyunsaturated fatty acids essential nutrients in infancy? Proceedings of the Fourth International Congress on Essential Fatty Acids and Eicosanoids (in press).

27. Makrides M, Neumann MA, Simmer K, Pater J & Gibson R (1995). Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet 345:1463-

28. Makrides M, Neumann MA & Gibson RA (1996). Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition. Eur J Clin Nutr 50:352-7.

29. Marmor MF, Arden GB, Nilsson SEG & Zrenner E (1989). Standard for clinical electroretinography. Arch Ophthalmol 107:816-9.

30. Martinez M (1995). Polyunsaturated fatty acids in the developing human brain, erythrocytes and plasma in peroxisomal disease: Therapeutic implications. J Inherit Metab Dis 18:61-75.

31. Reisbick S, Neuringer M & Gohe E (1994). Increased look duration in paired comparisons by rhesus monkey infants with n-3 fatty acid deficiency (n-3 FAD). Soc Neurosci Abstr 20:1696.

32. Uauy R, Birch DG, Birch EE, Hoffman D & Tyson J (1993). Visual and brain development in infants as a function of essential fatty acid supply provided by the early diet. In: Dobbing J, (eds.) Lipids, Learning, and the Brain: Fats in Infant Formulas. Dobbing J, (eds.), pp. 21-38. Columbus, OH: Ross Laboratories.

33. Vanderhoof J, Gross S, Hegyi T, et al. (1997). A new arachidonic acid (ARA) and docosahexanoic acid (DHA) supplemented preterm formula: growth and safety assessment. Pediatr Res 41:242A (abstr).

34. Werkman SH & Carlson SE (1996). A randomized trial of visual attention of preterm infants fed docosahexanoic acid until nine months. Lipids 31:91-7

35. Willatts P, Forsyth JS, DiModugno MK, Varma S & Colvin M (1998). Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 352:688-91.

Repository Staff Only: item control page